News & Events about Clearside Biomedical Inc.
ALPHARETTA, Ga., April 12, 2023 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc.(Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS), announced today that George Lasezkay, Pharm.D., J.D., President and Chief...
ALPHARETTA, Ga., Feb. 06, 2023 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc.(NASDAQ:CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS), today announced that its Chief Medical Officer and Chief Development ...
Clearside Biomedical Inc(NASDAQ: CLSD) announced results from the Extension Study of its OASIS Phase 1/2a trial of CLS-AX (axitinib) administered by suprachoroidal injection via SCS Microinjector in neovascular age-related macular degeneration participants.
read more...
Thinking about buying stock in Macy's, Immunic, LexinFintech, Provention Bio, or Clearside Biomedical? Thinking about buying stock in Macy's, Immunic, LexinFintech, Provention Bio, or Clearside Biomedical? PR Newswire NEW YORK, Nov. 17, 2022 NEW YORK, Nov. 17, 2022 /PRNewswire...
Latest Ratings for CLSD
DateFirmActionFromTo Mar 2022JMP SecuritiesMaintainsMarket Outperform Jul 2021HC Wainwright & Co.Initiates Coverage OnBuy Jun 2021WedbushMaintainsOutperform
View More Analyst Ratings for CLSD
View the Latest Analyst Ratings
read more...